Unigestion Holding’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-9,747
| Closed | -$920K | – | 208 |
|
2021
Q3 | $920K | Buy |
9,747
+896
| +10% | +$84.6K | 0.04% | 144 |
|
2021
Q2 | $858K | Sell |
8,851
-786
| -8% | -$76.2K | 0.03% | 179 |
|
2021
Q1 | $937K | Buy |
9,637
+1,892
| +24% | +$184K | 0.03% | 162 |
|
2020
Q4 | $742K | Sell |
7,745
-1,304
| -14% | -$125K | 0.03% | 164 |
|
2020
Q3 | $870K | Buy |
+9,049
| New | +$870K | 0.03% | 130 |
|